tiprankstipranks
Advertisement
Advertisement

TRAX Stock Latest News

First Tracks Biotherapeutics price target raised to $60 from $30 at Wedbush
The FlyFirst Tracks Biotherapeutics price target raised to $60 from $30 at Wedbush
1d ago
ARGX
FBRX
First Tracks Biotherapeutics price target raised to $55 from $30 at Wells Fargo
PremiumThe Fly
First Tracks Biotherapeutics price target raised to $55 from $30 at Wells Fargo
1d ago
FBRX
TRAX
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential
PremiumRatings
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition Potential
2d ago
TRAX
After Forte acquisition, H.C. Wainwright says First Tracks could be target
PremiumThe Fly
After Forte acquisition, H.C. Wainwright says First Tracks could be target
2d ago
ARGX
FBRX
First Tracks Biotherapeutics price target raised to $48 from $40 at Barclays
PremiumThe Fly
First Tracks Biotherapeutics price target raised to $48 from $40 at Barclays
8d ago
TRAX
First Tracks Biotherapeutics price target raised to $44 from $30 at H.C. Wainwright
PremiumThe FlyFirst Tracks Biotherapeutics price target raised to $44 from $30 at H.C. Wainwright
19d ago
FBRX
TRAX
Premium
Ratings
Buy Rating on First Tracks (TRAX) Driven by Strengthening IL-15/CD122 Pathway Validation and Upcoming ANB033 Clinical Catalysts in Celiac Disease and Vitiligo
21d ago
TRAX
First Tracks Biotherapeutics initiated with an Overweight at Wells Fargo
Premium
The Fly
First Tracks Biotherapeutics initiated with an Overweight at Wells Fargo
2M ago
TRAX
Emily Bodnar Reiterates Buy on AnaptysBio, Keeps $30 Price Target on ANB033 Progress and Solid Cash Runway
PremiumRatings
Emily Bodnar Reiterates Buy on AnaptysBio, Keeps $30 Price Target on ANB033 Progress and Solid Cash Runway
3M ago
TRAX
Two new option listings and one option delisting on May 11th
PremiumThe Fly
Two new option listings and one option delisting on May 11th
3M ago
TRAX
WLAC
First Tracks Biotherapeutics files to sell 10.5M shares of common for holders
PremiumThe Fly
First Tracks Biotherapeutics files to sell 10.5M shares of common for holders
3M ago
TRAX
AnaptysBio price target lowered to $93 from $95 at Piper Sandler
PremiumThe Fly
AnaptysBio price target lowered to $93 from $95 at Piper Sandler
3M ago
GSK
ANAB
First Tracks Biotherapeutics initiated with an Overweight at Piper Sandler
PremiumThe FlyFirst Tracks Biotherapeutics initiated with an Overweight at Piper Sandler
3M ago
TRAX
First Tracks Biotherapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
First Tracks Biotherapeutics initiated with a Buy at H.C. Wainwright
3M ago
TRAX
TRAX: Event-Driven Immunology Catalyst Play With Differentiated Pipeline and Valuation Upside Supporting Buy Rating
Premium
Ratings
TRAX: Event-Driven Immunology Catalyst Play With Differentiated Pipeline and Valuation Upside Supporting Buy Rating
3M ago
TRAX
First Tracks Biotherapeutics initiated with an Outperform at Leerink
PremiumThe Fly
First Tracks Biotherapeutics initiated with an Outperform at Leerink
3M ago
ANAB
TRAX
First Tracks Biotherapeutics initiated with an Overweight at Barclays
PremiumThe Fly
First Tracks Biotherapeutics initiated with an Overweight at Barclays
3M ago
TRAX
First Tracks Biotherapeutics initiated with an Overweight at JPMorgan
PremiumThe Fly
First Tracks Biotherapeutics initiated with an Overweight at JPMorgan
3M ago
TRAX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >